The Precision Peptide Company Inc.
PNGAF
$0.34
-$0.01-1.48%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -467.74% | -459.23% | -329.85% | -56.99% | 12.23% |
| Total Depreciation and Amortization | 5,400.00% | 3,373.68% | 2,438.46% | 2,800.00% | -57.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,601.16% | 1,521.65% | 902.91% | -98.60% | -75.97% |
| Change in Net Operating Assets | -424.06% | -124.04% | -135.32% | 184.86% | -70.42% |
| Cash from Operations | -235.76% | -528.46% | -415.69% | -96.53% | -43.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -22.85% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.62% | -- | -- | -- | -- |
| Total Debt Issued | 461.80% | 355.66% | 461.80% | -- | -- |
| Total Debt Repaid | -497.04% | -- | -- | -- | -- |
| Issuance of Common Stock | 173.79% | 441.44% | 535.17% | 1,058.38% | 265.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 195.04% | 451.81% | 532.05% | 1,013.07% | 253.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 200.00% | -- |
| Net Change in Cash | 330.83% | 48.08% | 831.99% | 1,036.21% | 154.58% |